problematic
FDA Commissioner: Use Generic Alternatives to Recalled J&J Meds
Yesterday the FDA said that an April inspection of the problematic plant had turned up raw materials contaminated by certain bacteria that may cause infections.
Polluting the Literature with PAINs
There’s an article out from a group in Australia on the long-standing problem of “frequent hitter” compounds. Everyone who’s had to work with high-throughput screening data has had to think about this issue, because it’s clear that some compounds are nothing but trouble.








Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice